Immune to Cancer: The CRI Blog
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward
Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.
-
Kicking Off the 2019 CRI Immunotherapy Patient Summit Series: A Saturday of Learning and Networking in San Diego
More than 200 patients, caregivers, and advocates attended an Immunotherapy Patient Summit in San Diego on Saturday,…
-
CRI Hosts Academic and Industry Experts for “Immuno-Oncology: A Future Look”
CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June…
-
Watch and Learn – “Immuno-Oncology: A Future Look” Event Video Recording
Watch the full video recording of June 21’s Immuno-Oncology: A Future Look event, featuring Drs. Jim Allison,…
-
MUFG Pedal to the Medal: CRI Cycling Challenge
Fifty-five employees from the MUFG came together for the second annual “Pedal to the Medal: CRI Cycling Challenge,” a…
-
Riding with a Purpose: Answer to Cancer Studio Cycling Event
At the second annual Answer to Cancer studio cycling event hosted by the CRI Associate Board, 36 dedicated…
-
CRI Celebrates a Future #Immune2Cancer on June 14 – Wear White Day
Supporters, scientists, patients, and advocates participated in CRI’s annual Wear White Day for a Future Immune to…
-
“Cancer Immunotherapy Insights from ASCO” Twitter Chat Recap #CIMchat
CRI hosted a Twitter Chat, moderated by STAT’s Sharon Begley, discussing takeaways from the ASCO19 conference last…